Kenneth E Ugen

Title: Innovations in Cancer Treatment by Kenneth E Ugen

Introduction

Kenneth E Ugen is a notable inventor based in Tampa, FL (US), recognized for his significant contributions to the field of cancer treatment. With a total of 8 patents, Ugen has developed innovative methods that aim to improve the efficacy of cancer therapies.

Latest Patents

One of Ugen's latest patents is a method for the treatment of malignancies. This method involves injecting an effective dose of a plasmid encoded for IL-12, B7-1, or IL-15 into a cancerous tumor. Following the injection, at least one high voltage, short duration pulse is administered to the tumor. The electroporation pulses are delivered at a voltage of at least 700 V/cm for a duration of less than 1 millisecond. The treatment can be administered in a two-treatment protocol with a 7-day interval between treatments or in a three-treatment protocol with specific intervals of four days and three days between treatments. This innovative approach not only results in tumor regression but also induces an immune memory response that helps prevent the formation of new tumors.

Career Highlights

Throughout his career, Kenneth E Ugen has worked with prestigious institutions such as the University of Pennsylvania and the University of South Florida. His work has been instrumental in advancing cancer treatment methodologies and enhancing patient outcomes.

Collaborations

Ugen has collaborated with notable colleagues, including David B Weiner and Richard M Heller, contributing to the development of groundbreaking cancer therapies.

Conclusion

Kenneth E Ugen's innovative approaches to cancer treatment exemplify the potential of modern medical research and technology. His work continues to inspire advancements in the fight against cancer.